Sector Chart BlossomHill Therapeutics, Inc.
Stocks
BLSM
US0951301003
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
11:30:29 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 26.20 USD | -2.29% |
|
+26.22% | - |
| 07:43am | BlossomHill Therapeutics Q2 Loss Widens | MT |
| 07:14am | Earnings Flash (BLSM) BlossomHill Therapeutics Posts Q2 Loss $8.75 a Share | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 822M | - | - | - | - | - |
| 46.18B | |||||
| 44.35B | |||||
| 42.21B | - | - | - | - | - |
| 40.19B | |||||
| 29.83B |
Select your edition
All financial news and data tailored to specific country editions
